NASDAQ · Biotechnology

Niki BioSolutions, Inc. (NIKI) Stock

$4.26 -1.39% NASDAQ: NIKI Healthcare

Valuation

MetricValue
Price$4.26
Market Cap$346922
P/E Ratio-0.25
P/B Ratio0.02
P/S Ratio0.00
EPS (TTM)$-1.89
52-Week High$259.00
52-Week Low$4.14
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.94%
ROA-7.29%
ROCE-2.86%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.15
Current Ratio0.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$1.0M$0$0$0
Operating Profit$-19.0M$-18.0M$-11.0M$-4.0M$-2.0M
Net Profit$-25.0M$-10.0M$-3.0M$-4.0M$-1.0M
EPS$-715.00$-275.00$-62.00$-78.00$-19.00
Op Margin-1245.6%-1351.0%-2457.5%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$21.0M$21.0M$16.0M$19.0M
Total Liabilities$4.0M$13.0M$5.0M$4.0M$5.0M
Cash$8.0M$2.0M$2.0M$1.0M$3.0M
Borrowings$0$7.0M$3.0M$3.0M$3.0M

Latest News

Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR) GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-12.0M$-8.0M$-1.0M$-2.0M
Investing Cash Flow$16.0M$2.0M$1.0M$0$0
Financing Cash Flow$1.0M$0$0$0$-1.0M
Net Cash Flow$5.0M$-3.0M$-3.0M$-1.0M$3.0M
Free Cash Flow$-15.0M$-13.0M$-8.0M$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.21
FCF Yield-139.00%
Quick Ratio0.78
Interest Coverage-5.48
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held47.24%
Institutions Held0.46%
Institutions Float Held0.87%
Institutional HolderSharesReport Date
Citadel Advisors Llc9,2422026-03-31
Susquehanna International Group, LLP1,6782026-03-31
Xtx Topco Ltd1,5062026-03-31
Morgan Stanley1,3262026-03-31
Renaissance Technologies, LLC1,1842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $333.97 -1.89% 38.93 $4.91T 0.32%
MSFTMicrosoft Corporation $533.54 +2.09% 28.68 $3.96T 0.76%
GOOGLAlphabet Inc. $352.65 +1.25% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $260.95 +2.71% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $723.60 +0.38% 27.93 $1.84T 0.28%

About Niki BioSolutions, Inc.

Niki BioSolutions, Inc. is headquartered in US.

Niki BioSolutions, Inc. (NIKI) stock trades at $4.26 with a market capitalization of $346922. The stock is valued at a price-to-earnings (P/E) ratio of -0.25, price-to-book of 0.02, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.14 and $259.00, and currently trades 98.4% below its 52-week high.

On profitability, Niki BioSolutions, Inc. generates a return on equity (ROE) of -5.94%, return on capital employed of -2.86%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1170.66 +0.09% JNJ Johnson & Johnson $259.67 +1.24% ABBV AbbVie Inc. $275.32 +1.06% MRK Merck & Company, Inc. Common Stock (new) $144.70 +1.63% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.99 +1.09% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $657.21 +0.80% AMGN Amgen Inc. $410.68 +0.80% GILD Gilead Sciences, Inc. $149.76 +1.81% ABT Abbott Laboratories $99.64 +1.16% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides